Beclomethasone

Beclomethasone

SCHEMBL5486743

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 9/20 1.00
CYP3A4 P08684 7/20 1.00
NR3C1 P04150 7/20 1.00
NFKB1 P19838 4/20 1.00
LMNA P02545 3/20 1.00
ABCB11 O95342 2/20 1.00
BLM P54132 2/20 1.00
MAPT P10636 1/20 1.00
GAA P10253 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
HSD17B10 Q99714 4/20 0.77
PGR P06401 4/20 0.77
AR P10275 3/20 0.77
TSHR P16473 2/20 0.77
PMP22 Q01453 2/20 0.77
MEN1 O00255 1/20 0.77
CYP2D6 P10635 1/20 0.77
KMT2A Q03164 1/20 0.77
APEX1 P27695 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beclomethasone SCHEMBL5037570 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL7755941 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL1462741 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL18762039 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL13046625 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL8809468 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL3183 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL7614763 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL5037573 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL5486747 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021360-A1 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase EPIGENESIS PHARMACEUTICALS, LLC 2007-01-25 US claimed
US-4081541-A Steroid derivatives RORER ITALIANA S.P.A. (IT) 1978-03-28 US claimed
US-20070021360-A1 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase EPIGENESIS PHARMACEUTICALS, LLC 2007-01-25 US disclosed
US-20050288265-A1 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copd MEDA PHARMA GMBH & CO. KG (DE) 2005-12-29 US disclosed
US-20040023935-A1 Inhalation compositions, methods of use thereof, and process for preparation of same DEY, L.P. 2004-02-05 US disclosed
US-4081541-A Steroid derivatives RORER ITALIANA S.P.A. (IT) 1978-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023935-A1 Inhalation compositions, methods of use thereof, and process for preparation of same IL5, CHRM3, NOX5 HIF1A 1481/4885CYP3A4 1342/4885NR3C1 967/4885
US-20070021360-A1 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase RECQL, GSS, DDX17 HIF1A 1076/4885CYP3A4 2529/4885NR3C1 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.